دورية
Chemotherapy and signaling
| العنوان: | Chemotherapy and signaling |
|---|---|
| المؤلفون: | Bagnyukova, Tetyana V., Serebriiskii, Ilya G., Zhou, Yan, Hopper-Borge, Elizabeth A., Golemis, Erica A., Astsaturov, Igor |
| المصدر: | Cancer Biology and Therapy; November 2010, Vol. 10 Issue: 9 p839-853, 15p |
| مستخلص: | In recent years, oncologists have begun to conclude that chemotherapy has reached a plateau of efficacy as a primary treatment modality, even if toxicity can be effectively controlled. Emerging specific inhibitors of signaling and metabolic pathways (i.e., targeted agents) contrast with traditional chemotherapy drugs in that the latter primarily interfere with the DNA biosynthesis and the cell replication machinery. In an attempt to improve on the efficacy, combination of targeted drugs with conventional chemotherapeutics has become a routine way of testing multiple new agents in early phase clinical trials. This review discusses the recent advances including integrative systematic biology and RNAi approaches to counteract the chemotherapy resistance and to buttress the selectivity, efficacy and personalization of anti-cancer drug therapy. |
| قاعدة البيانات: | Supplemental Index |
Full Text Finder | تدمد: | 15384047 15558576 |
|---|---|
| DOI: | 10.4161/cbt.10.9.13738 |